ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia.

Matthew D Hickey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.